Location Brisbane, Queensland, Australia Regions Asia-Pacific (APAC), Australasia Gender Male
LinkedIn View on LinkedIn
Dr. Mitch J. Nelles is the Chief Operating Officer for XDx.
He has more than 20 years of management and research and development experience in a variety of in vitro diagnostic (IVD) technology and business areas.
Dr. Nelles joined XDx from bioMerieux Inc. where he was Vice President of North America Research and Development and responsible
for product development and project management for the bacteriology, molecular diagnostics, immunodiagnostics and hemostasis business franchises.
Prior to his work at bioMerieux, Dr. Nelles served as the Vice President of R&D at TriPath Oncology (TriPath Imaging) where he led the efforts to develop molecular based products for the diagnosis and prognosis of breast and cervical cancer.
Earlier in his career, Dr. Nelles held a variety of technical and managerial positions of increasing responsibility, including Vice President, Transfusion Medicine and Immunodiagnostic Assay R&D at Ortho Clinical Diagnostics (Johnson and Johnson) where he led the worldwide research and development activities in support of the blood screening, blood typing, immunodiagnostic and RhoGAM business franchises.
Dr. Nelles received his Bachelor’s Degree from Rutgers College in biological sciences.
His Ph.D. in Immunology / Biomedical Sciences from the University of Texas, Health Sciences Center at Dallas (UTHSCD)/Southwestern Medical School.
He completed Postdoctoral Training in Immune Regulation at Brandeis University.
